Background: The aim is to measure the association between fibromyalgia syndrome (FMS) and post-traumatic stress disorder (PTSD), mood and anxiety disorders using reliable psychiatric diagnoses according to Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) and with a case–control design. Methods: Case–control study with cases (71 consecutive female patients with FMS) and controls (284 subjects without FMS), randomly drawn after a gender- and age-matching technique from the database of an epidemiological survey. Psychiatric diagnoses were conducted according to DSM-IV and carried out by clinical staff using a structured interview (Advanced Neuropsychiatric Tools and Assessment Schedule). QoL was measured by Short Form Health Survey (SF-12). Results: The lifetime prevalence of major depressive disorder (MDD; 43.7% vs 8.1%, p <.0001), bipolar disorder (BD; 21.1% vs 0.7%, p <.0001), PTSD (8.4% vs 1.4%, p <.0001) and panic disorder (28.2% vs 5.6%, p <.001) was higher in people with FMS than in controls. People with FMS showed a poorer QoL than controls on the SF-12 (26.43 ± 6.04 vs 37.45 ± 5.80, p <.0001). Those with comorbidity with MDD and BD showed a mean SF-12 score of 24.75 ± 6.31 versus 29.52 ± 4.84 (N = 25) of people with FMS without any mood disorder (p =.002). The attributable burden of FMS in worsening QoL was found comparable to that of serious chronic diseases such as multiple sclerosis. Conclusion: FMS is a disorder that ‘in itself’ can have a devastating impact on an individual’s life. The frequency of the association with major depressive and bipolar disorders increases the impact on the QoL of people with FMS. One of the causes of this association appears to be the extreme vulnerability to chronic stress that this disorder involves. The findings have important clinical significance: the physician must interpret in the right dimension and with dignity the suffering of the people with FMS.

The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life / Carta, M. G.; Moro, M. F.; Pinna, F. L.; Testa, G.; Cacace, E.; Ruggiero, V.; Piras, M.; Romano, F.; Minerba, L.; Machado, S.; Freire, R. C.; Nardi, A. E.; Sancassiani, F.. - In: INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY. - ISSN 0020-7640. - 64:7(2018), pp. 647-655. [10.1177/0020764018795211]

The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life

Romano F.;
2018

Abstract

Background: The aim is to measure the association between fibromyalgia syndrome (FMS) and post-traumatic stress disorder (PTSD), mood and anxiety disorders using reliable psychiatric diagnoses according to Diagnostic and Statistical Manual of Mental Disorders (4th ed.; DSM-IV) and with a case–control design. Methods: Case–control study with cases (71 consecutive female patients with FMS) and controls (284 subjects without FMS), randomly drawn after a gender- and age-matching technique from the database of an epidemiological survey. Psychiatric diagnoses were conducted according to DSM-IV and carried out by clinical staff using a structured interview (Advanced Neuropsychiatric Tools and Assessment Schedule). QoL was measured by Short Form Health Survey (SF-12). Results: The lifetime prevalence of major depressive disorder (MDD; 43.7% vs 8.1%, p <.0001), bipolar disorder (BD; 21.1% vs 0.7%, p <.0001), PTSD (8.4% vs 1.4%, p <.0001) and panic disorder (28.2% vs 5.6%, p <.001) was higher in people with FMS than in controls. People with FMS showed a poorer QoL than controls on the SF-12 (26.43 ± 6.04 vs 37.45 ± 5.80, p <.0001). Those with comorbidity with MDD and BD showed a mean SF-12 score of 24.75 ± 6.31 versus 29.52 ± 4.84 (N = 25) of people with FMS without any mood disorder (p =.002). The attributable burden of FMS in worsening QoL was found comparable to that of serious chronic diseases such as multiple sclerosis. Conclusion: FMS is a disorder that ‘in itself’ can have a devastating impact on an individual’s life. The frequency of the association with major depressive and bipolar disorders increases the impact on the QoL of people with FMS. One of the causes of this association appears to be the extreme vulnerability to chronic stress that this disorder involves. The findings have important clinical significance: the physician must interpret in the right dimension and with dignity the suffering of the people with FMS.
2018
bipolar disorder; fibromyalgia syndrome; major depressive disorder; post-traumatic stress disorder; quality of life; case-control studies; comorbidity; diagnostic and satistical manual of mental disorders; female; fibromyalgia; humans; italy; male; middle aged; mood disorders; prevalence; psychiatric status rating scales; quality of life; stress disorders, post-traumatic; surveys and questionnaires
01 Pubblicazione su rivista::01a Articolo in rivista
The impact of fibromyalgia syndrome and the role of comorbidity with mood and post-traumatic stress disorder in worsening the quality of life / Carta, M. G.; Moro, M. F.; Pinna, F. L.; Testa, G.; Cacace, E.; Ruggiero, V.; Piras, M.; Romano, F.; Minerba, L.; Machado, S.; Freire, R. C.; Nardi, A. E.; Sancassiani, F.. - In: INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY. - ISSN 0020-7640. - 64:7(2018), pp. 647-655. [10.1177/0020764018795211]
File allegati a questo prodotto
File Dimensione Formato  
Carta_Impact_2018.pdf

solo gestori archivio

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 107.18 kB
Formato Adobe PDF
107.18 kB Adobe PDF   Contatta l'autore

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1406237
Citazioni
  • ???jsp.display-item.citation.pmc??? 10
  • Scopus 29
  • ???jsp.display-item.citation.isi??? 21
social impact